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Patients with sickle cell disease (SCD) utilize the emergency department (ED) frequently 
due to limited access to adult health care providers. Few providers are knowledgeable 
about caring for patients with sickle cell disease. This quantitative study’s purpose and 
research questions addressed whether there was a correlation between ED utilization and 
ED length of stay (LOS) pre- and post-enrollment in an adult comprehensive sickle cell 
clinic between the years of 2012 and 2017. The Donabedian framework was used to 
examine the structure, process, and outcomes related to the benefits of care in a sickle 
cell center. The independent variables of pre- and post-enrollment of patients in a sickle 
cell specialty center in relation to the dependent variables of ED utilization and ED LOS 
were analyzed using a chi-square test and a paired sample t test, and age was measured as 
a covariate using linear regression. Results indicated a significant difference in ED 
utilization between the pre- and post-enrollment groups, with an increased ED utilization 
in the pre-enrollment group compared to patients enrolled in the SCD clinic group. There 
was no statistical significance for ED LOS in the pre-enrollment group compared to the 
post-enrollment group. Results also indicated a significant correlation between ED 
utilization and age, but no significant correlation between ED LOS and age. The positive 
social change benefits of this study include the advantage of specialty clinics for SCD 
patients to prevent ED admissions because of improvements in care, the importance of 
SCD specialty clinics for different regions, and the role health care administrators have 
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Section 1: Foundation of the Study and Literature Review  
The lack of sickle cell providers has been highlighted as one of the factors that 
affects emergency department (ED) utilization in adult patients with sickle cell disease 
(Ogu & Billet, 2018). The literature showed a gap regarding the administrative benefits, 
such as ED utilization and ED length of stay (LOS), of comprehensive sickle cell clinics. 
ED utilization is defined as the use of the ED department by SCD patients, and ED LOS 
is defined as the amount of time from the patient checking in to the ED to discharge from 
the ED or admission to the hospital. Unnecessary utilization of the ED could increase 
health care costs (Enard & Ganeline, 2013). 
National estimates of SCD-related ED visits in the United States were $2.96 
million (Lankzkron et al., 2010), and annual health care expenditure for SCD 
hospitalizations was over $900 million (Shah et al., 2019). ED utilization and LOS are 
important considerations for hospital administrators because unnecessary ED utilization 
can increase the overall cost of care and duplication of services, which can further burden 
hospitals (Ho et al., 2017).  
The current study addressed ED utilization and ED LOS of patients who used the 
ED in the hospital system prior to attending an adult sickle cell center (pre-enrollment) 
and after attending an adult sickle cell center (post-enrollment). This study’s dependent 
variables included ED utilization and ED LOS, and the independent variables included 
pre-enrollment and post-enrollment.  
The information from this study could help providers understand and appreciate 
the best standard of care for SCD patients, which could translate into cost reduction for 
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health care systems. This study may also increase the understanding of the benefits for 
sickle cell patients when they attend comprehensive sickle cell centers, including how 
comprehensive sickle cell centers affect the ED utilization and LOS. In turn, this study 
may motivate hospital administrators to invest in sickle cell clinics. 
Problem Statement 
Caring for adult SCD patients is challenging due to limited adult providers who 
are educated in SCD (Ogu & Billet, 2018). Limited data are available on the effectiveness 
of adult comprehensive sickle cell clinics. Some studies suggested an increase in ED 
utilization when patients attend sickle cell centers, and some studies suggested a decrease 
in ED utilization when patients attend sickle cell centers (Artz et al., 2010; Binding et al., 
2014; Smeltzer et al., 2016.) The problem was the evidence was not conclusive regarding 
the ED utilization patterns of patients who attend a comprehensive sickle cell center. 
Previous studies indicated adult patients with SCD received fragmented care due to a lack 
of specialized teams devoted to adult SCD (Ogu & Billet, 2018; Reich et al., 2019; Ter-
Minassian et al., 2019). In a national study, primary care physicians did not feel 
comfortable treating SCD because they did not have enough education about SCD to 
understand the needs of these patients (Mainous et al., 2015). Due to the lack of sickle 
cell providers, there was limited evidence regarding the administrative benefits, such as 
ED utilization and ED LOS, among adult sickle cell patients who receive care in sickle 
cell centers. The limited evidence that did exist was inconclusive. In the current study, I 
compared the administrative outcomes that affect medical costs, such as ED utilization 
and ED LOS of adult SCD patients. The purpose of this quantitative study was to 
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examine the correlation in ED utilization and ED LOS among adult sickle cell patients 
who received care at an adult sickle cell center in Tennessee. The patients’ ED utilization 
and ED LOS were compared from pre-enrollment to the center and post-enrollment to the 
center between the years of 2012 and 2017. Pre-enrollment was defined as prior to being 
a patient of the adult sickle cell center, and post-enrollment was defined as after being a 
patient of the adult sickle cell center.  
Smeltzer et al. (2016) looked at a pediatric comprehensive sickle cell center and 
found that hospitalizations and clinic visits increased when the sickle cell center was 
located closer to the patient, suggesting that sickle cell patients who lived further away 
from a center may have inadequate medical care and access to care. Smeltzer et al. 
suggested the decrease in hospitalizations and clinic visits for patients who lived farther 
away from the comprehensive sickle cell center could be related to underreporting ED 
and inpatient utilization in other medical facilities closer to the patients’ homes. 
However, Smeltzer et al. also found that patients’ overall ED utilization rate was lower 
than the national averages for the pediatric SCD population.  
Binding et al. (2014) investigated how sickle centers in high and low disease 
prevalence areas tended to show a reduction of admission rates, but the study included 
only a small sample size and was not designed to consider the ED utilization and LOS 
with SCD centers. The literature on whether sickle cell clinics reduce hospital and ED 
utilization was mixed and inconclusive. Some researchers found that using a 
multidisciplinary approach decreased ED utilization and using a SCD center reduced 
hospital inpatient admission rates (Blinder et al., 2015; Powell et al., 2016; Simpson et 
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al., 2017), while Smeltzer et al. (2016) suggested that the closer a patient lives to the ED 
or center, the ED utilization increases.  
 The data for the current study were obtained from a sickle cell center that 
provides multidisciplinary care and individualized pain plans based on the best standard 
of care, and hematologists specialized in treating SCD. The multidisciplinary approach at 
the center includes weekly team meetings between different health providers such as 
medical doctors from adult and pediatric hematology, ED providers, and primary care; 
nurse practitioners; and other ancillary health care staff such as nurses, social workers, 
and case managers. The results of this study may help administrators understand the 
benefits of sickle cell patients attending comprehensive sickle cell centers, including 
understanding how comprehensive sickle cell centers affect ED utilization and LOS. In 
turn, this study may motivate hospital administrators to invest in sickle cell clinics to help 
reduce the total cost of care. Hospital revenue in the ED is tied to improving performance 
metrics such as ED wait times, patients leaving without being seen, ED LOS, decisions to 
admit, and patient satisfaction (Feinberg & Stone-Griffith, 2016).  
Purpose of the Study 
The purpose of this quantitative study was to determine whether there was a 
correlation in ED utilization and ED LOS among adult sickle cell patients who received 
care at an adult sickle cell center, pre- and post-enrollment to the clinic, between the 
years of 2012 and 2017. ED utilization and LOS are important considerations for hospital 
administration because unnecessary ED utilization can increase the overall cost of care 
and duplication of services, which can further burden the hospitals (Ho et al., 2017). 
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When the ED LOS is long, there is one less ED bed available to another patient, which 
directly impacts the hospital’s revenue (Feinberg & Stone- Griffith, 2016).  It is in the 
best interest of hospital administrators to pay careful attention to ED optimization to 
improve performance and quality measures (Feinberg & Stone-Griffith, 2016). Hospitals 
are under regulatory pressure to reduce ED costs, improve efficiency, and increase 
throughput capacity, which then ties to hospital reimbursement. The current study would 
help determine administrative benefits of sickle cell centers.  
The independent variables included pre- and post-enrollment to the sickle cell 
center. The dependent variables included ED utilization (frequency of ED visits) and ED 
LOS. The study addressed the dependent variables of the same patients with SCD prior to 
being enrolled into the sickle cell specialty center (pre-enrollment) and after being 
enrolled to the center (post-enrollment) to determine whether there was a statistical 
difference in ED LOS. The results of this study may provide insight regarding the 
benefits of providing specialized SCD care, which may include lower ED utilization, 
lower LOS, improved quality of care, and lower cost of care. The study may help health 
care leaders determine the usefulness of sickle cell clinics and may help administrators 
determine the benefits of investing in more comprehensive sickle cell centers.  
ED utilization and LOS are important considerations for hospital administration 
because unnecessary ED utilization can increase the overall cost of care and duplication 
of services, such as repeating labs or diagnostics that could be performed as an outpatient 
instead, which can further burden the hospitals (Ho et al., 2017). It is in the best interest 
of hospital administrators to pay careful attention to ED optimization to improve 
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performance and quality measures (Feinberg & Stone-Griffith, 2016). Feinberg and 
Stone-Griffith (2016) stated that hospitals are under regulatory pressure to reduce ED 
costs, improve efficiency, and increase throughput capacity, which then ties to hospital 
reimbursement. 
Adult sickle cell patients tend to utilize the ED or have increased inpatient 
admissions secondary to SCD-related complications (Chappidi et al., 2013; Cline et al., 
2018; Glassberg, 2012). The increased complications may be related to the lack of sickle 
cell clinics and providers. The findings from this research may contribute to positive 
social change for the sickle cell community by increasing accessibility to comprehensive 
sickle cell centers, which may afford patients the opportunity to receive the best 
evidence-based care. Additionally, this study may encourage increased funding for sickle 
cell clinics or sickle cell providers by providing administrative insights into the optimal 
care of patients with SCD.  
Research Questions and Hypotheses 
RQ1: Is there a statistically significant difference in ED utilization among adult 
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment 
between the years of 2012 and 2017?  
Ho1: There is no statistically significant difference in ED utilization among adult 
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment 
between the years of 2012 and 2017.  
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Ha1: There is a statistically significant difference in ED utilization among adult 
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment 
between the years of 2012 and 2017.  
RQ2: Is there a statistically significant difference in ED length of stay among 
adult sickle cell patients before enrollment in an adult sickle cell clinic and after 
enrollment between the years of 2012 and 2017?  
Ho2: There is no statistically significant difference in ED length of stay among 
adult sickle cell patients before enrollment in an adult sickle cell clinic and after 
enrollment between the years of 2012 and 2017. 
Ha2: There is a statistically significant difference in ED length of stay among 
adult sickle cell patients before enrollment in an adult sickle cell clinic and after 
enrollment between the years of 2012 and 2017. 
RQ3: Is there a correlation between ED utilization and age among adult sickle cell 
patients in patients between the years of 2012 and 2017?  
Ho3: There is no correlation between ED utilization and age among adult sickle 
cell patients in patients between the years of 2012 and 2017. 
Ha3: There is a correlation between ED utilization and age among adult sickle cell 
patients in patients between the years of 2012 and 2017. 
RQ4: Is there a correlation between ED LOS and age among adult sickle cell 
patients in patients between the years of 2012 and 2017?  
Ho4: There is no correlation between ED LOS and age among adult sickle cell 
patients in patients between the years of 2012 and 2017. 
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Ha4: There is a correlation between ED LOS and age among adult sickle cell 
patients in patients between the years of 2012 and 2017.  
Theoretical Foundation of the Study 
I used the Donabedian (1985) framework to examine the structure, process, and 
outcomes of attending a sickle cell center. The model provided a foundation for 
understanding whether the effectiveness of an adult sickle cell center reduces the use of 
the ED. The Donabedian framework includes three categories: structure, process, and 
outcome. The structure provides a model for determining how care is organized, the 
process determines what is known to be the best evidence-based medical care, and the 
outcome emphasizes the quality measures that affect the end result of care (Donabedian, 
1985; Van Houdt et al., 2013). The Donabedian framework related to the current study in 
the following ways: The structure was the comprehensive sickle cell clinic; the process 
was the best practice standards already researched in sickle cell, which included 
multidisciplinary care and individualized care plans; and the outcome related to the use of 
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Nature of the Study  
The study had a retrospective correlational quantitative design. The independent 
variables were pre- and post-enrollment to the center, and the dependent variables were 
ED utilization and ED LOS. A chi-square test, a paired sample t test, and a linear 
regression analysis were used to compare the pre- and post-enrollment groups; linear 
regression was used to compare groups in relation to age. 
 I used a secondary data set collected by the former medical director of an adult 
sickle cell clinic in a southern U.S. state. The data set was a convenience sample to 
investigate the effectiveness of an adult sickle cell clinic related to ED utilization. The 
data set included data on all patients who came to the ED through a large hospital system 
in Tennessee and were diagnosed with SCD for the time frame of 2012 to 2017. 
Permission to access the secondary data set was obtained by completing the Collaborative 
Institutional Training Initiative (CITI) training and submitting a request to the 
organization’s institutional review board (IRB) committee.  
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Each patient was counted as a unique patient, each visit was counted as an 
encounter, and patients may have had more than one encounter. The ED patient list was 
cross-referenced with the sickle cell center’s list of patients to determine whether the 
patient attended the adult center and when the patient was first enrolled in the clinic. The 
data set also included the inpatient (IP) utilization, the LOS, the insurance carrier, and 
demographic information. All of the secondary data were de-identified, and no personal 
information was known to me.  
Literature Search Strategy 
To better understand the association between ED utilization and ED LOS in the 
sickle cell population, several databases were used to retrieve the most current literature 
on ED utilization in SCD, ED LOS in SCD, and factors that affect SCD ED utilization. 
Selected articles relating to the care of patients with SCD and outcomes such as ED 
utilization and ED LOS were identified. The keywords searched were sickle cell disease, 
inpatient (IP) utilization, ED utilization, and comprehensive sickle cell centers. Database 
searches were my primary means of searching for related articles. The following Walden 
University databases and search engines were used: EBSCO, Medline, PubMed, and the 
Thoreau multi database search. The search was focused initially on ages 18 years and 
older, but limited data existed in the adult population, so the search was expanded to 
include the pediatric population as well. The publication dates for scholarly articles 
ranged from 2009 to 2018. 
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Literature Review Related to Key Variables and/ or Concepts 
The purpose of the literature review was to synthesize studies completed by 
researchers about ED utilization and ED LOS (the dependent variables) in SCD patients, 
and enrollment in a comprehensive sickle cell center (the independent variable). The 
literature review is divided into the following sections: (a) the general overview of SCD, 
(b) the typical barriers that adult sickle cell patients face, (c) the factors that affect ED 
utilization and LOS in adult sickle cell patients, and (d) current evidence on sickle cell 
centers. 
General Overview of SCD 
SCD is a group of inherited red blood cell disorders that can lead to multiple 
complications to the patient, such as vaso-occlusive pain crises and acute chest syndrome 
(Bojanowski, 2010). SCD results in hemolytic anemia and small vessels’ blockade, which 
can lead to vaso-occlusive episodes and/or organ failure (Shah et al., 2019). The blockage 
of blood vessels can cause the following complications: acute chest syndrome secondary 
to sickling of blood vessels of the lungs; acute pain crises, also known as vaso-occlusive 
pain crises, which is caused secondary to sickled blood flow and deoxygenated blood; 
brain complications such as strokes; and heart problems such as ischemic heart disease 
and pulmonary hypertension (Lee et al., 2019; National Heart, Lung, and Blood Institute, 
n.d.; Shah et al., 2019). The sickle cell complications cause sickle cell patients to have 
increased hospitalizations and to frequently utilize the ED (Hemker et al., 2011). 
Approximately 85% of the SCD-related ED visits had vaso-occlusive crises as the 
primary reason for admission, and the other 15% of the ED visits contributed to SCD 
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complications (Blinder et al., 2015). The other most common complications included 
infectious and parasitic disease and cerebrovascular complications such as seizures and 
strokes (Shah et al., 2019). Other sickle cell complications included splenic crises, which 
can lead to immunocompromise, gallstone, and priapism in males (Carden et al., 2016).  
SCD is a disease that affects fewer than 200,000 people nationwide, and 
consequently the disease does not receive much research funding (Lee et al., 2019). 
People living with SCD have limited access to comprehensive care because providers do 
not have enough education/comfort to treat the disease (Mainous et al., 2015) and 
therefore have more difficulty managing patients’ pain (Lee et al., 2019). When the sickle 
cell pain cannot be managed at home, ED utilization is increased (Smeltzer et al., 2016). 
Soboto (2011) performed a survey of 30 pediatric SCD centers and found that only 18 
centers transitioned their patients to adult hematologists specializing in SCD. The 
mortality rates of young adults who were transitioning with SCD increased by two- to 
threefold (Hamideh & Alvarez, 2013). 
Typical Barriers That Adult SCD Patients Face 
SCD has limited research funding because there is a limited number of patients 
diagnosed with this illness (Lee et al., 2019). Limited research has shown a lack of 
educated providers in the SCD adult population (Mainous et al., 2015). The lack of health 
care providers in SCD adult care has been demonstrated in the overutilization of EDs for 
SCD care due to lack of access to care (Blinder et al., 2015; Ogu & Billet, 2018; Smeltzer 
et al., 2018; Ter-Minassian et al., 2019). Decreased adherence to health maintenance 
visits, such as regular checkups and regular assessment of blood levels, was noted more 
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among patients without private insurance, possibly related to health literacy, economic 
status, and access to health care issues (Smeltzer et al., 2016).  
Other barriers that adult SCD patients face is decreased access to health care, such 
as the unsuccessful transition of pediatric patients to adult sickle cell care, and increased 
distance from a sickle cell center to the patient’s house (Smeltzer et al., 2016). Other 
barriers include low socioeconomic status (Cronin et al., 2018; Smeltzer et al., 2016) and 
having private insurance versus Medicaid (Amendah et al., 2010; Cronin et al., 2018; 
Smeltzer et al., 2016). Age and fragmented care are also documented barriers to caring 
for the sickle cell patient (Blinder et al., 2015; Smeltzer et al., 2016).  
Children who have SCD received adequate standardized care, but the patients 
who reach adulthood did not receive the same care due to a lack of providers (Ter-
Minassian et al., 2019). Patients with high ED reliance incurred more days in the hospital 
and significantly higher health care costs (Blinder et al., 2015). SCD patients who 
transition from youth to adulthood have difficulty finding an adult provider devoted to 
SCD care (Ter-Minassian et al., 2019). Total costs per patient per month were lower for 
pediatric patients compared with adult patients due to fragmented care (Kauf et al., 2009). 
Adults comprised 75% of the SCD hospital admissions (Artz et al., 2010). Cronin et al. 
(2018) reported that financial security, health literacy, spirituality, and lacking cues to 
action like reminders were also perceived as barriers to sickle cell care. The current study 
addressed access to care by determining whether the comprehensive sickle cell specialty 
clinic affected the ED utilization and LOS before and after patients enrolled in the center.  
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Factors That Affect ED Utilization and LOS in Adult SCD Patients 
Sickle cell patients face multiple barriers that make optimal management of their 
sickle cell disease difficult (Gray et al., 2018; Smelter et al., 2015). The challenges of 
sickle cell care contribute to poor sickle cell outcomes, increased utilization of the ED, 
increased hospitalizations, and increased cost of care (Blinder et al., 2015; Carden et al., 
2016; Smeltzer et al., 2016). Carden et al. (2016) reported that increased disease-specific 
knowledge increased ED utilization as patients became more aware of SCD 
complications. Alternatively, other research suggested that health literacy and education 
affected ED utilization (Aisiku et al., 2009; Cronin et al., 2018). Age and disease severity 
have also been shown to increase ED utilization (Aisiku et al., 2009; Blinder et al., 2015). 
Multiple researchers found a common barrier was fragmented care or decreased providers 
specialized in treating the adult sickle cell patient (Blinder et al., 2015; Ogu & Billet, 
2018; Ter-Minassian et al., 2019). Multiple studies suggested that a multidisciplinary 
approach to sickle cell care reduced ED utilization (Powell et al., 2016; Simpson et al., 
2017). 
Sickle Cell Centers 
Fragmented care is a major barrier to adult sickle cell care (Blinder et al., 2015; 
Koch et al., 2014; Ogu & Billet, 2018; Ter-Minassian et al., 2019). The evidence 
regarding the correlation between ED utilization and comprehensive sickle cell centers 
was mixed and limited (Blinder et al., 2015; Powell et al., 2016; Simpson et al., 2017; 
Smeltzer et al., 2016). Lavelle et al. (2018) found that Federally Qualified Health Centers 
that provide comprehensive care increased ED utilization but decreased the number of 
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outpatient clinic visits; however, when the analysis was adjusted for the case-mix, the 
difference was attenuated. Similarly, patients who had more disease-specific knowledge, 
which is a type of learning that empowers caregivers and patients to make life-changing 
decisions, ED utilization increased as patients were more empowered of knowing their 
disease and when they needed to utilize the ED; comprehensive multidisciplinary centers 
are known to provide disease-specific knowledge (Carden et al., 2016). Alternatively, 
Blinder et al. (2015) found that ED reliance increased among post-transition patients and 
continued into adulthood secondary to decreased health care access once patients became 
adults. Similarly, Simpson et al. (2017) found that sickle cell centers that provided best 
practice advisories, an ED protocol, and a medical home, which is a method of providing 
comprehensive and continuous care to adults with an emphasis of care coordination and 
communication among high or super-utilizers, showed a tendency to decrease ED 
utilization and LOS; however, the sample size for this study was small and included only 
super-utilizers.  
Simpson et al. (2017) and Powell et al. (2016) provided information on how a 
multidisciplinary approach affected ED utilization in the sickle cell population. The 
researchers found that monthly meetings, best practice advisories, and ED protocols 
helped to decrease ED visits, ED LOS, IP admissions, and IP LOS. The practices of 
monthly meetings, individualized pain plans for ED protocols, and best practice 
advisories are consistent with comprehensive sickle cell clinics’ practices.  
ED utilization for SCD patients was shown to be lower when a multidisciplinary 
approach was used, which included monthly team meetings and development of 
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individualized care plans (Powell et al., 2016; Simpson et al., 2017). Adult sickle cell 
centers used a multidisciplinary approach to care, and Powell et al. (2016) and Simpson 
et al. (2017) demonstrated that a multidisciplinary approach reduces ED utilization; 
however, there was a gap in the literature regarding whether a relationship exists between 
attending a comprehensive sickle cell center and ED utilization. Patients with SCD tend 
to utilize ED services more than clinic services due to the lack of sickle cell providers 
(Blinder et al., 2015). Cline et al. (2018) suggested alternative venues to manage 
uncomplicated vaso-occlusive crises such as day hospitals or ED observation units to 
decrease hospital admissions.  
Smeltzer et al. (2016) found that the greater the distance between the 
comprehensive sickle cell clinic and the patient’s house, the lower the ED utilization. 
Smeltzer et al. reported that patients who lived further away from a sickle cell center 
sometimes forego medical care. Smeltzer et al. also found that patients living within 35 
miles of the hospital had 1.75 times the rate of hospitalization than those living 35 or 
more miles away. The results of this study indicated that the closer a patient lives to the 
hospital, the greater the ED utilization and hospitalizations, and therefore the greater the 
cost. However, Smeltzer et al. attributed this to underreporting of patients who lived 
farther away. Smeltzer et al. also found that hospitalizations and ED utilization rates in 
their multidisciplinary clinic were significantly lower than the national averages.  
Binding et al. (2014) found that sickle cell centers with a lower prevalence of 
sickle cell population had similar ED visits and hospital admissions compared to sickle 
cell centers with a higher prevalence of sickle cell population. Artz et al. (2010) found a 
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downward trend in admissions, 30-day readmissions, and LOS after the establishment of 
a multidisciplinary sickle cell center. Both these studies showed mixed reviews of sickle 
cell centers’ administrative benefits, therefore demonstrating a gap in the literature.  
Comprehensive sickle cell clinics provide multidisciplinary care and 
individualized care plans that improve patient outcomes (Powell et al., 2016). Adult 
sickle cell patients have multiple complications, including vaso-occlusive pain crises and 
acute chest syndrome, which can increase ED utilization and hospitalizations (Blinder et 
al., 2015; Carden et al., 2016; Hemker et al., 2011). Most ED visits by adult SCD patients 
are due to a vaso-occlusive pain crisis; when the pain is not adequately addressed, it leads 
to a hospitalization (Blinder et al., 2015). 
Literature Review Conclusion 
The research findings regarding the correlation between comprehensive sickle cell 
centers and ED utilization are mixed, with some studies suggesting increased ED 
utilization (Carden et al., 2016; Lavelle et al., 2018; Smeltzer et al., 2016) and other 
studies suggesting decreased ED utilization (Powell et al., 2016; Simpson et al., 2017). 
The current study was conducted to determine the relationship between ED utilization 
and pre- and post-enrollment at a comprehensive sickle cell center. The literature did not 
indicate whether there are benefits for adults who attend comprehensive sickle cell 
centers with use of the ED.  
Definitions 
Best practice advisories: Evidence-based recommendations based on best 
practices (Simpson et al., 2017).  
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Comprehensive sickle cell clinic: A clinic that specializes in the care of adult 
sickle cell patients by using a multidisciplinary approach, which may include monthly 
team meetings and development of individualized care plans (Powell et al., 2016; 
Simpson et al., 2017). 
Disease-specific knowledge: This type of learning empowers principal caregivers 
of children to make life-changing decisions that can be measured by behavior change 
over time (Carden et al., 2016). 
ED (emergency department) utilization: Emergency department utilization by 
sickle cell patients. ED utilization was calculated by total use, called ED total and those 
visits that did not result in an admission, called ED independent (Epstein et al., 2006). 
ED LOS (emergency department length of stay): The amount of time from 
checking into the ED to the discharge from the ED or admission to the hospital.  
Fragmented care: When sickle cell patients transition from pediatric to adult care, 
their medical care is interrupted, which can then result in poorer clinical outcomes 
secondary to inconsistent and inadequate access to care (Blinder et al., 2015; Koch et al., 
2014).  
Health literacy: The degree to which individuals have the capacity to obtain, 
process, and understand basic health information and services needed to make 
appropriate health decisions (Carden et al., 2016). 
Post-enrollment: A patient’s ED utilization and ED LOS after attending the adult 
sickle cell center. 
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Pre-enrollment: A patient’s ED utilization and ED LOS before attending the adult 
sickle cell center.  
SCD (sickle cell disease): A group of inherited disorders of red blood cells in 
which abnormal hemoglobin is produced (Epstein et al., 2007). 
Transition: This is the phase when a young adult receives uninterrupted, 
developmentally appropriate medical care (Gray et al., 2018). 
Vaso-occlusive crises: These are also referred to as pain crises, which are a 
blockade of vessels secondary to sickled blood flow (Bojanowski, 2010; Lee et al., 2019). 
Assumptions 
It was important to acknowledge the assumptions that affected this study. I 
assumed that patients only went to the ED based on where the data for this study were 
collected. If a patient visited another ED, the information was not included in the 
secondary data. The study did not account for the ED utilization at other health care 
systems. The final assumption was that patients who attended the adult sickle cell clinic 
chose the associated health care hospital as their medical home. 
Scope and Delimitation, and Limitations 
The scope of the study concerned the methodology, which was quantitative and 
correlational with conclusions derived from a secondary data set. The previous medical 
director created this secondary data set at an adult sickle cell clinic, and the information 
technology analyst provided access to the data. The data set included data for all patients 
who had a primary diagnosis of SCD and had come to the ED through the health care 
system associated with the sickle cell center. Each patient visit was considered an 
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encounter, and each encounter was determined to be either pre-enrollment to the center or 
post-enrollment to the center. Additionally, the data set included the frequency of 
utilization, the LOS, the insurance carrier, demographic information, utilization before 
the center was established, and utilization after the center was established.  
Permission to access the data set was accomplished by completing the CITI 
training and communicating with the organization’s IRB. The independent variables that 
were analyzed in this study included pre-enrollment to the center and post-enrollment to 
the center, and the dependent variables included ED utilization and ED LOS. The study 
did not account for other factors that may have affected the results such as demographics, 
disease severity, distance from the patient’s house to the ED, and insurance carriers.  
The study was limited to data of patients who came to the ED through the hospital 
system associated with the adult sickle cell center in Tennessee. This meant that the 
results may not be generalizable to the entire sickle cell population. In addition, I did not 
consider sickle cell patients who received care at other sickle cell centers.  
Significance, Summary, and Conclusions 
The study’s results may provide insight regarding the benefits of specialized SCD 
care, which may include lower ED utilization and lower LOS. In return, this could 
improve the quality of care while potentially lowering the cost of care. The study may 
help health care leaders determine the usefulness of sickle cell clinics and whether it is 
effective to invest in more comprehensive sickle cell centers. 
Adult sickle cell patients tend to utilize the ED or have increased IP admissions 
secondary to SCD-related complications (Chappidi et al., 2013; Cline et al., 2018). The 
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increased number of complications may be related to the lack of sickle cell 
clinics/providers. The current findings may contribute to positive social change for the 
sickle cell community, sickle cell clinics, and sickle cell providers by providing standards 
and administrative insight into the optimal care of patients with SCD. 
The gap in the literature pertained to how ED utilization correlated to attending a 
sickle cell center. The literature showed mixed findings related to sickle cell clinics and 
ED utilization. One study suggested an increase in utilization when the distance from the 
patient’s house to the center was closer (Smeltzer et al., 2016). Other studies suggested a 
decrease in ED utilization when receiving care at a sickle cell center (Powell et al., 2016; 
Simpson et al., 2017). The current study may allow researchers, administrators, and 
medical teams to determine how ED utilization may be affected when patients attend a 
comprehensive sickle cell center. Section 2 provides information regarding the research 




Section 2: Research Design and Data Collection 
In the previous section, I provided an extensive review of the current literature 
related to ED utilization and LOS in the sickle cell patients and the literature related to 
the benefits of comprehensive sickle cell centers in the adult sickle cell population. 
Although multiple researchers have explored the benefits of sickle cell centers among the 
pediatric sickle cell population, the research among the adult sickle cell population has 
been mixed. My study addressed the administrative outcome of ED utilization and ED 
LOS in an adult sickle cell clinic.  
The purpose of this quantitative study was to examine the correlation in ED 
utilization and LOS among adult sickle cell patients who received care at the adult 
comprehensive sickle cell clinic pre- and post-enrollment to the center, between the years 
of 2012 and 2017. The ED LOS is directly related to how many ED beds are available to 
treat a patient, which affects hospital reimbursement; ED utilization is related to ED 
optimization to improve performance and quality measures, which also improves 
reimbursement (Feinberg & Stone-Griffith, 2016). The independent variables were pre- 
and post-enrollment to the sickle cell center, and the dependent variables were ED 
utilization (the frequency of ED visits) and ED LOS. This section includes the research 
design, methodology, threats to validity, and a summary.  
Research Design and Rationale 
The dependent variables were ED utilization and ED LOS, and the independent 
variables were the pre- and post-enrollment to the adult sickle cell center. The research 
design was retrospective, correlational, and quantitative. A chi-square test and a paired 
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sample t test were used to compare ED utilization and ED LOS in the pre- and post-
enrollment group, and a regression analysis was used to compare age to ED utilization 
and ED LOS. The design choice included a secondary data set to compare pre- and post-
enrollment, which required me to have IRB approval prior to accessing the data set at the 
organization providing the data. This data approval process was time-consuming and took 
2 months. Another constraint with this design choice was that the data set included data 
collected from 2012 to 2017, meaning the data set was not the most current. However, 
this design was the most appropriate for this study, and matched previous studies that 
compared pre- and post-enrollment data. 
Powell et al. (2018) used a retrospective study of unplanned acute care use (ED 
and IP admissions) pre- and post-initiation of a multidisciplinary care team intervention 
in a single urban academic health center in Pennsylvania. Simpson et al. (2016) also used 
a retrospective pre- and post-implementation design; however, this study included only 
10 subjects. The study by Ter-Minassian et al. (2019) was a retrospective cross-sectional 




The target population for the current study was adult sickle cell patients age 18 
years or older who received services at the emergency rooms of the hospital system 
associated with the adult sickle cell clinic. A total of 428 encounters of patients who went 
to the ED were examined, including the pre- and post-enrollment groups.  
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Sampling and Sampling Procedures 
The secondary data set that was used in this study was previously collected by the 
health care system. The sampling strategy used for the original data was convenience 
sampling. The secondary data set that I used included de-identified information and did 
not include the patients’ name, date of birth, medical record number, address, zip codes, 
or social security numbers. The letter of approval to access the data set was included in 
the appendix along with a copy of the organization’s IRB approval. The data set was 
saved on my personal laptop that was password protected.  
The data set included data on all the patients who came to the ED through the 
health care system associated with the sickle cell clinic who had a diagnosis of SCD. 
Each patient visit was considered an encounter, and each encounter was determined to be 
either pre-enrollment to the clinic or post-enrollment to the clinic. Additionally, the data 
set included the frequency of utilization, the LOS, the insurance carrier, demographic 
information, the utilization before the center was established, and the utilization after the 
center was established. The inclusion criteria included adult sickle cell patients age 18 
years or older who were enrolled in the adult sickle cell center for the years 2012 through 
2017. The exclusion criteria included any sickle cell patients younger than 18 years of 
age. 
Power Analysis 
The power analysis tool used was the G*Power, a free power analysis tool (Faul 
et al., 2007). Based on the power analysis, the required sample size for the logistic 
regression analysis was 84 (power = 0.80, alpha = 0.05, and predicted moderate effect 
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size = 0.3). The analysis used was a priori logistic regression. The power and the alpha 
level used were standard numbers that are typically used. The effect size that was used 





Instrumentation and Operationalization of Constructs  
 The secondary data set was obtained from a large sickle cell center. Permission to 
use this data set was received by both creators of the data via email communication. The 
IRB program at the organization received my request to use the data, and my name was 
added to access the data set. The data set included data on all patients who came to the 
ED through the health care system associated with the clinic who had a diagnosis of SCD 
from the years 2012 to 2017. Each patient visit was considered an encounter, and each 
encounter was determined to be either pre-enrollment to the center or post-enrollment to 
the center. Additionally, the data set included the frequency of utilization, the LOS, the 
insurance carrier, demographic information, the utilization before the center was 
established, and the utilization after the center was established. The data were tested for 
accuracy by the IT systems analyst using sample patients. I looked at the ED utilization 
prior to being enrolled in the adult center and after being enrolled in the center. 
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The independent variables included the pre-enrollment to the adult sickle cell 
center, which was coded as 1, and post-enrollment to the adult sickle cell center, which 
was coded as 2. The ED utilization was measured by looking at the number of check-ins 
a patient made to an ED in the health care system associated with the sickle cell clinic, 
and the ED LOS was measured from the time a patient checked in to the ED to the time 
the patient was discharged from the ED. I looked at the pre-enrollment ED utilization, 
pre-enrollment ED LOS, post-enrollment ED utilization, and post-enrollment ED LOS. 
Table 1 includes a description of the variables. 
Table 1 
 
Description of Variables 
Independent variables Dependent variables Covariates 
Pre-enrollment to the 
adult sickle cell center 
ED utilization Age 
Post-enrollment to the 
adult sickle cell center 
ED LOS Age 
 
Data Analysis Plan 
I analyzed data from the secondary data set using the Statistical Package for the 
Social Sciences (SPSS) Version 25. The pre-enrollment to the clinic group was coded as 
a 1, and the post-enrollment to the clinic was coded as 2. Additionally, if the patient had 
an ED visit, the encounter was coded as 1; other visit types were coded as 0.  
Research Questions and Hypotheses 
RQ1: Is there a statistically significant difference in ED utilization among adult 
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment 
between the years of 2012 and 2017?  
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Ho1: There is no statistically significant difference in ED utilization among adult 
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment 
between the years of 2012 and 2017.  
Ha1: There is a statistically significant difference in ED utilization among adult 
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment 
between the years of 2012 and 2017.  
RQ2: Is there a statistically significant difference in ED length of stay among 
adult sickle cell patients before enrollment in an adult sickle cell clinic and after 
enrollment between the years of 2012 and 2017?  
Ho2: There is no statistically significant difference in ED length of stay among 
adult sickle cell patients before enrollment in an adult sickle cell clinic and after 
enrollment between the years of 2012 and 2017. 
Ha2: There is a statistically significant difference in ED length of stay among 
adult sickle cell patients before enrollment in an adult sickle cell clinic and after 
enrollment between the years of 2012 and 2017. 
RQ3: Is there a correlation between ED utilization and age among adult sickle cell 
patients in patients between the years of 2012 and 2017?  
Ho3: There is no correlation between ED utilization and age among adult sickle 
cell patients in patients between the years of 2012 and 2017. 
Ha3: There is a correlation between ED utilization and age among adult sickle cell 
patients in patients between the years of 2012 and 2017. 
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RQ4: Is there a correlation between ED LOS and age among adult sickle cell 
patients in patients between the years of 2012 and 2017?  
Ho4: There is no correlation between ED LOS and age among adult sickle cell 
patients in patients between the years of 2012 and 2017. 
Ha4: There is a correlation between ED LOS and age among adult sickle cell 
patients in patients between the years of 2012 and 2017.  
Detailed Analysis Plan 
The research was a retrospective correlational quantitative design. The 
independent variables were pre- and post-enrollment to the center, and the dependent 
variables were ED utilization and ED LOS. Using SPSS Version 25, I compared the pre- 
and post-enrollment group using a chi-square test and a paired sample t test, and I 
compared the covariate of age using linear regression. Multiple studies suggested that the 
use of the ED increases with age (Blinder et al., 2015; Hemker et al., 2011; Kauf et al., 
2009). 
Results were interpreted using the odds ratio, which is a relative measure of effect 
that allowed the comparison of the intervention group relative to the comparison group. 
The confidence interval indicated the level of uncertainty around the measure of effect. I 
used a confidence interval (CI) of 95%, which is a common CI used in research studies. 




Threats to Validity 
External Validity 
 Data for this study were obtained from a secondary data set from one hospital 
system and one comprehensive sickle cell center; therefore, the results are not 
generalizable to the total population. I looked at one sickle cell center in the region and 
did not look at any other sickle cell centers. Therefore, if patients utilized other EDs in 
the region, those visits were not accounted for and the sample was not representative of 
the whole population. However, the secondary data were comprehensive and obtained 
from multiple years, which provided a thorough analysis of the benefits of one large 
sickle cell specialty clinic.  
Internal Validity 
 Errors of misdiagnosis upon presentation to the ED were identified as a threat to 
this study’s validity. Furthermore, there was a chance of human error with delayed 
documentation, which may have affected the ED LOS. Because sickle cell patients have 
multiple complications, mortality was an aspect of this study that may have also affected 
the study’s internal validity.  
Construct Validity 
 The accuracy of the data collected in this data set was only as good as the data 
entered by the hospital and clinic staff. Simpson et al. (2017) used a similar methodology 
of using a pre- and post-enrollment design to assess ED and IP utilization; however, the 
study was limited to a small sample and included super-utilizers only. I used similar types 




Permission to access the secondary data set was obtained from the specialty clinic 
by completing the CITI training and adding my name to the IRB submission. The data set 
was downloaded and stored on my password-protected personal laptop and on a personal 
USB drive, and both were stored in a safe when not in use. Furthermore, the laptop that 
was used to access the data set was encrypted. Device encryption helped protect the files 
and folders from unauthorized access in case the device was stolen. Before analyzing the 
data, I transferred the data from Excel to SPSS. The secondary data were de-identified 
and did not include the patients’ identifiable information such as the names, dates of 
birth, addresses, or social security numbers. Additionally, IRB approval through Walden 
University was obtained when the proposal was approved. The approval number from the 
Walden IRB was 12-31-20-0735724.  
Summary 
In Section 2, I described the quantitative methodology for this correlational study. 
I used SPSS Version 25, and the population consisted of patients prior to enrollment in 
the sickle cell clinic, the post-enrollment group, and their ED utilization. The chosen 
analysis was a chi-square test and a paired sample t test, and a linear regression analysis 
was used to compare age as a covariate. Section 3 provides the statistical findings relative 




Section 3: Presentation of the Results and Findings 
The purpose of this quantitative study was to examine whether there was a 
correlation in ED utilization and ED LOS among adult sickle cell patients who received 
care at an ER in a major health care system prior to attending the clinic and after 
enrollment in the clinic between the years of 2012 and 2017. The study was conducted to 
determine administrative benefits of sickle cell centers, demonstrate the need for funding 
of sickle cell centers, and encourage evidence-based care for sickle cell patients. The 
independent variables were pre-enrollment and post-enrollment to the sickle cell center, 
and the dependent variables were ED utilization (the frequency of ED visits), and ED 
LOS. The covariate was age of patients.  
The research questions and hypotheses were as follows:  
RQ1: Is there a statistically significant difference in ED utilization among adult 
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment 
between the years of 2012 and 2017?  
Ho1: There is no statistically significant difference in ED utilization among adult 
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment 
between the years of 2012 and 2017.  
Ha1: There is a statistically significant difference in ED utilization among adult 
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment 
between the years of 2012 and 2017.  
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RQ2: Is there a statistically significant difference in ED length of stay among 
adult sickle cell patients before enrollment in an adult sickle cell clinic and after 
enrollment between the years of 2012 and 2017?  
Ho2: There is no statistically significant difference in ED length of stay among 
adult sickle cell patients before enrollment in an adult sickle cell clinic and after 
enrollment between the years of 2012 and 2017. 
Ha2: There is a statistically significant difference in ED length of stay among 
adult sickle cell patients before enrollment in an adult sickle cell clinic and after 
enrollment between the years of 2012 and 2017. 
RQ3: Is there a correlation between ED utilization and age among adult sickle cell 
patients in patients between the years of 2012 and 2017?  
Ho3: There is no correlation between ED utilization and age among adult sickle 
cell patients in patients between the years of 2012 and 2017. 
Ha3: There is a correlation between ED utilization and age among adult sickle cell 
patients in patients between the years of 2012 and 2017. 
RQ4: Is there a correlation between ED LOS and age among adult sickle cell 
patients in patients between the years of 2012 and 2017?  
Ho4: There is no correlation between ED LOS and age among adult sickle cell 
patients in patients between the years of 2012 and 2017. 
Ha4: There is a correlation between ED LOS and age among adult sickle cell 
patients in patients between the years of 2012 and 2017.  
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This section contains the data collection information of the secondary data set, the 
analysis and results of the research questions, and a summary.  
Data Collection of Secondary Data Set 
The information in section 3 includes the process for the collection of the 
secondary data set, how the data were collected, and the time frame of the data collection. 
Section 3 also includes the statistical analyses of data from the secondary data set 
collected from a sickle cell center. Data were analyzed using a paired sample t test to 
analyze the LOS in the pre-enrollment to the clinic group and post-enrollment to the 
clinic group. A chi-square analysis was used to analyze the ED utilization, which was a 
categorical test to compare the pre- and post-enrollment to the clinic groups. Linear 
regression was used to analyze age for both groups. Descriptive statistics included age, 
gender, and financial status (which included the type of insurance).  
Obtaining Data, Time Frame, and Discrepancies of the Data Set 
Obtaining Data 
The secondary data set was collected from one sickle cell center located in a 
southern U.S. state. This convenience sample data set was obtained to investigate the 
effectiveness of an adult sickle cell clinic related to ED utilization and ED LOS. 
Permission to access the secondary data set was obtained by completing the CITI 
training. After this the data set owners added me to the data set organization’s IRB. After 
receiving Walden University’s IRB approval, I analyzed the de-identified data in IBM 
SPSS Version 25. The data set included data on all patients with a diagnosis of SCD who 
were admitted to the ED in a major hospital system for the time frame of 2012 to 2017.  
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Data Filters and Exclusions 
The data set consisted of 622 patient pre- and/or post-enrollment to the clinic 
encounters. From these 622 encounters, 81 patients were removed from the data set 
because they did not have visits in both the pre- and post-enrollment groups. After 
removing the 81 patients, I analyzed a total of 412 patient encounters. Furthermore, to 
accurately answer Research Question 2 using a paired sample t test, I considered only 37 
patients because these patients had matched samples in both the pre-enrollment to the 
clinic group and post-enrollment to the clinic group. The clinic group included 210 
encounters in the pre-enrollment in an adult sickle cell clinic group and 112 encounters in 
the post-enrollment in an adult sickle cell clinic group. Additionally, removing the 
encounters with more than 10 ED visits may have provided a more normal distribution 
pattern; however, these patient encounters were not removed to provide a true picture of 
the ED utilization and ED LOS patterns in the sickle cell population.  
Data Filters and Inclusions  
The data set consisted of 412 encounters of sickle cell patients and included data 
on patients who went to a major hospital’s ED department. All patients considered were 
18 years old or older. Data that were analyzed from the data set included the medical 
record number, financial number, final classification that included whether the patient 
was in a pre- or post-enrollment phase, date of birth, age, gender, race, marital status, 
admit type (including emergency, urgent care, or elective), admit date, discharge date, 
LOS, and the initial appointment date. The secondary data set for this study included 412 
encounters, which was far greater than the G*Power a priori power analysis required 
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sample size of 84 (power = 0.80; alpha = 0.05; and predicted moderate effect size = 0.3). 
The de-identified data from Excel were imported into IBM SPSS Version 25 for 
statistical analysis. The nonnumeric variables were recoded to ensure all data had 
numerical values for better analysis.  
Descriptive Statistics 
The nonnumeric data for admit type were recoded into numbers for more accurate 
analysis. Table 2 represents the demographic data including distribution of gender, race, 
and marital status. Table 3 includes the distribution of patients in the pre- and post-







 Frequency Percent Cumulative 
Percent 
Female 183 44.4 44.4 
Male 229 55.6 100.0 




 Frequency Percent Cumulative 
Percent 
Black of African 
Amercican 
408 99.0 99.0 
 
Multiple 2 0.5 99.5 
Other/ Unknown 2 0.5 100.0 






 Frequency Percent Cumulative 
Percent 
Divorced 3 0.7 0.7 
Married 79 19.2 19.9 
Single 330 80.1 100.0 







Mean Statistic Std. Deviation 
Statistic 
Age 18 53 27.63 7.507 
LOS 0.564 29.951 6.146 4.086 
Mortality 0.00 1.00 0.00243 0.049 
 
  
As shown in Table 2, 44.4% (n = 183) of the patient encounters were women, and 
55.6% (n = 229) of the patient encounters were men. In addition, 99% (n = 408) of the 
patient encounters were noted to be Black or African American, 0.5% (n = 2) of the 
patient encounters were of multiple races, and 0.5% (n = 2) of the patient encounters 
were noted as Other/Unknown. The data were representative of the sickle cell population 
where 1 in 400 African Americans and 1 in 19,000 Hispanic individuals have sickle cell 
disease (Stone, 2015). Most of the encounters were noted to be single (80.1%), 19.2 % 
were married, and 0.7% were divorced.  
 The descriptive statistics indicated that the mean age of the total 
encounters was 27.63 years, with a minimum age of 18 years and a maximum age of 53 
years. The mean LOS in the ED was noted to be 6.146 hours, with a minimum of 0.564 
hours and a maximum of 29.951 hours. The mean mortality rate was 0.002 encounters 
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with a minimum mortality of 0 encounters and a maximum of 1 encounter. Table 3 
includes the distribution of patients in the pre- and post-enrollment groups, and Table 4 
includes the admit type group (emergency, elective, or urgent).  
Table 2 
 
Pre-Enrollment to Clinic and Post-Enrollment to Clinic 
 Frequency Percent Cumulative percent 
Post-enrollment 197 47.8 47.8 





Types of Patient Admissions 
 Frequency Percent Cumulative percent 
Elective 17 4.1 4.1 
Emergency 285 69.2 73.3 
Newborn 1 0.2 73,5 
Urgent 109 26.5 100.0 
Total 412 100.0   
 
Table 3 indicates the distribution of patients in the before enrollment to the clinic 
(pre-enrollment group) and after enrollment to the clinic (post-enrollment group). Table 4 
includes the distribution in the admit type group (emergency, elective, or urgent). Table 3 
shows that 47.8% (n = 197) of the patient encounters were categorized in the post-
enrollment group, and 52.2% (n = 215) of the patient encounters were categorized in the 
pre-enrollment group. In addition, the data set was categorized into 4.1% (n = 17) of the 
encounters in the elective admission type, 69.2% (n = 285) of the encounters in the 
emergency admission type, 0.2% (n = 1) of the encounters in the newborn admission 
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type, and 26.5% (n = 109) of the encounters in the urgent care admission type. The data 
showed that only 285 encounters were related to ED utilization.  
Study Results 
After completing the collection, organization, and description of the secondary 
data set, I used inferential statistics to test the hypotheses of the research questions. The 
inferential statistics tests that were used included the chi-square test of association and 
the paired sample t test. Research Question 1 was answered using the chi-square test of 
association, and Research Question 2 was answered using a paired sample t test.  
Research Question 1 
RQ1: Is there a statistically significant difference in ED utilization among adult 
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment 
between the years of 2012 and 2017?  
To answer this research question, the chi-square test was used. A chi-square test is 
nonparametric test to examine a possible association between two nominal variables 
(Allwright, 2019). This test allows a researcher to evaluate the association, interpret the 
chi-square, and interpret the strength of the association (Allwright, 2019). A chi-square 
association has no more than 20% of the expected counts as less than 5. When expected 
counts are equal to or close to the observed count, there is no relationship between the 
variables; when the alpha p value is less than 0.05, the results are considered significant, 
the null hypothesis can be rejected, and the alternative hypothesis can be accepted 
(Allwright, 2019). Mchugh (2013) reported the following assumptions for use of the chi-
square test: The data should be frequencies or counts and not percentages, and the levels 
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of the variables should be mutually exclusive. In the current study, both the independent 
and dependent variables were nominal levels of data. The dependent variables were ED 
utilization and ED LOS, and the independent variables were pre-enrollment to the clinic 
and post-enrollment to the adult sickle cell center. The ED utilization was counted in 
frequencies (1 for an ED visit and 0 for any other visit). Each encounter was mutually 
exclusive, where each encounter could not be in both the pre-enrollment to the clinic 
group and post-enrollment to the clinic group.  
A chi-square test was chosen for Research Question 1 because the data were 
collected as encounters and the variables were mutually exclusive. A patient encounter 
could not be in the pre-enrollment and post-enrollment group at the same point in time, 
and the dependent variable was nominal. The independent variable in the research 
question was pre-enrollment to the clinic or post-enrollment to the clinic. The dependent 
variable was whether the patients utilized the ED or not. Table 5 shows the cross-
tabulation, Table 6 shows the chi-square tests that were used, Table 7 shows the 
correlation test, and Table 8 shows the odds’ ratio (OR). Figure 3 shows the frequency of 
ED utilization in the pre-enrollment to the clinic group and post-enrollment to the clinic 
group. 
The results of the chi-square test showed that there was a statistically significant 
difference in ED utilization among adult sickle cell patients before enrollment in an adult 
sickle cell clinic and after enrollment between the years of 2012 and 2017 (chi-square = 
13.612a, df = 1, p < 0.05). The alpha value was noted to be .000, which was less than p 
value of .05, and therefore the null hypothesis was rejected and the alternate hypothesis 
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was accepted. The Pearson chi-square test was used to analyze the data because the 
expected counts in the pre-enrollment to the clinic, post-enrollment to the clinic, non-
emergency admit types, and ED utilization groups were all greater than 5.  
To analyze the strength of the correlation, the Cramer’s V test was used. The 
Cramer’s V value was noted to be RR= 0.182, which is RR < 1, so there was a negative 
association between post-enrollment and ED utilization; however, the effect size was 
small or weak. Additionally, the OR = 2.221 (95% CI: 1.448, 3.406) suggesting that the 
counts in the post-enrollment group were 2.221 times more likely to use the 
nonemergency admit types, and less likely to use the emergency admit type.  
The cross-tabulation table shows that in the post-enrollment group 39.6% of the 
counts were categorized in the nonemergency admit types, which included having an 
admit type of anything other than the emergency room, and 60.4% of the post-enrollment 
counts were categorized as having an emergency admit type. Alternatively, in the before 
registration to the clinic group, 22.8% of the counts were categorized in the 
nonemergency admit types, and 77.2% of the counts belonged in the emergency group. 
Figure 3 illustrates how the ED utilization in the post-enrollment group was lower than 
the pre-enrollment group; however, the nonemergency admit types category was higher 
in the post-enrollment group compared to the pre-enrollment group. The results indicated 
an increased use of other admit types such as elective admissions and/or urgent care 
admissions instead of ED utilization. 
For RQ1, the null hypothesis was rejected, and the alternate hypothesis was 
accepted. There was a statistically significant difference in ED utilization among adult 
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sickle cell patients in the pre-enrollment group and the post-enrollment group, with the 
OR and cross-tabulation findings showing ED utilization was less in the post-enrollment 
group. Table 5 shows the cross-tabulation table for ED utilization in the pre-enrollment to 
clinic group and post-enrollment to clinic group. Table 6 includes the Chi-square analysis 
comparing ED utilization in the pre-enrollment and post-enrollment to clinic, and table 7 










admit types  Emergency 
Final 
Classification 
Post-enrollment Count 78 119 197 
Expected Count 60.7 136.3 197.0 
% within Final 
classification 
39.6% 60.4% 100.0% 
Pre-enrollment Count 49 166 215 
Expected Count 66.3 148.7 215.0 
% within Final 
classification  
22.8% 77.2% 100.0% 
Total  Count 127 285 412 
Expected Count 127.0 285.0 412.0 
% within Final 
classification 







Chi-Square Tests for Association of Pre and Post-Enrollment to Sickle Cell Clinic and 
ED Utilization 
 








Pearson Chi-Square 13.612a 1 .000   
Continuity 
Correctionb 
12.836 1 .000 
  
Likelihood Ratio 13.681 1 .000   
Fisher’s Exact Test    .000 .000 
N of Valid Cases 412     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 60.73. 















N of Valid Cases 412  







Odd’s Ratio for Likeliness of Using the ED 
 
 Value 
95% Confidence Interval 
Lower Upper 
Odds Ratio for Final Classification (Post-
enrollment/ Pre-enrollment) 
2.221 1.448 3.406 
For cohort Non-emergency admit types  1.737 1.286 2.346 
For cohort Emergency Utilization  .782 .684 .895 







ED Utilization in Pre- and Post-Enrollment to the Clinic Groups 
 
 
Research Question 2 
RQ2: Is there a statistically significant difference in ED length of stay among 
adult sickle cell patients before enrollment in an adult sickle cell clinic and after 
enrollment between the years of 2012 and 2017?  
A paired t-test is used to compare two population means where you have two 
samples where observations in one sample can be paired with observations in the other 
sample (Walden University Academic Skills, 2020). The paired t test provides a 
hypothesis test of the difference between population means for a pair of random samples 
whose differences are approximately normally distributed (Walden University Academic 
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Skills, 2020). Statistical assumptions of the paired sample t-test include that the 
dependent variable should be a continuous variable; independent variables should consist 
of two categorical and related or matched groups; there should be no significant outliers 
and the groups should be normally distributed (Walden University Academic Skills, 
2020). The dependent variable is the ED LOS, which is a continuous variable, and the 
independent variable is the pre-enrollment and post-enrollment groups, which are 
nominal variables. The data set however was not normally distributed and will be 
described in detail later in the study. 
A paired sample t-test was used for research question 2 because the dependent 
variable (length of stay: LOS) is a continuous variable, and the independent variable is 
categorical and related (before enrollment to the clinic and after enrollment to the clinic). 
All the patients in this list were counted in both the pre-enrollment group or the post-
enrollment group. To create a paired sample, a total of 37 patients were used for this 
dataset, which looked at 210 encounters in the before registration to the clinic group, and 
112 encounters in the after registration to the clinic group. Since the sample size was 
greater than 20, a paired sample t-test was still used instead of the non-parametric test. To 
meet the assumption of using a paired sample t-test, the data had to be normally 
distributed. Figure 3 is a side-by-side bar graph that demonstrates the distribution of ED 
LOS in the pre-enrollment to clinic group compared to the distribution of ED LOS in the 
post-enrollment to clinic group. The standard error of skewness was 0.388, which is less 
than 0.5, which indicates the data is normally distributed.  
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The findings of the paired sample t-test demonstrates that the mean ED LOS of 
the pre-enrollment group, m = 28.01 hours, was higher than the mean ED LOS of the 
post-enrollment group, m = 19.45 hours. The mean difference between the before clinic 
enrollment ED LOS group and the after-clinic enrollment ED LOS group was m = 8.560, 
95% CI (6.904, 24.024). Furthermore, p=.269 is p > .05, therefore the null hypothesis is 
accepted and the alternate hypothesis is rejected indicating that there was no statistically 
significant difference in ED length of stay among adult sickle cell patients before 
enrollment in an adult sickle cell clinic and after enrollment between the years of 2012 
and 2017. 
A two-tailed paired sample t-test revealed that ED LOS in the pre-enrollment to 
clinic group (m = 28.01) was not significantly different than the ED LOS in the post-
enrollment to clinic group (m = 19.45), t (36) = 1.123, p < 0.05). The results of this study 
shows no strong evidence to suggest a statistically significant difference in ED LOS 
among adult sickle cell patients before enrollment in an adult sickle cell clinic and after 
enrollment in an adult sickle cell clinic (t = 11.123, df = 36, p > .05, 2 tailed test). 
However, it is important to note that although no significant difference was noted, the 
mean LOS of post-enrollment to the clinic was noted to be less than the mean LOS of the 
pre-enrollment to the clinic group. Table 10 represents the Means table of the paired 





ED LOS in the Pre-Enrollment to Clinic and Post-Enrollment to Clinic Group 
 
The mean ED LOS in the pre-enrollment group is 28.01 hours and the mean ED LOS in 
the post-enrollment group is 19.45 hours. Table 9 and 10 includes the means table for the 
paired sample t-test comparing ED LOS in the pre-enrollment and post-enrollment to the 





Means Table for Paired Sample t Test of ED LOS in Pre-Enrollment and Post-
Enrollment Groups 
 



























Interval of the 
Difference 
Lower Upper 
Pair 1 PreEnrolEDLOS – 
PostEnrolEDLOS 
8.560 46.381 7.625 -6.904 24.024 11.123 36 .269 
 
Research Question 3 
RQ3: Is there a correlation between ED utilization and age among adult sickle cell 
patients in patients between the years of 2012 and 2017? 
To analyze this research question, a linear regression analysis was used. To 
examine if there was a correlation in ED utilization and age, a linear regression analysis 
was used. The independent variable was age and the dependent variable was ED 
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utilization. Table 12 shows the Model summary table of ED utilization and age. The R-
value is the multiple correlation coefficient and has a value of 0.120, indicating a small 
level of prediction. The R square is the coefficient of determinization, and represents the 
proportion of variance in the dependent variable (ED utilization) that can be explained by 
the independent variables (age). The R square value is 0.014, indicating that age explains 
1.4% of the variability of ED utilization. Table 13 shows the ANOVA table of ED 
utilization with age. Table 13 shows whether the overall regression model is a good fit for 
the data. The table shows that the independent variables statistically significantly predict 
the dependent variable, F(1,410)= 6.012, p<.05, R square = 0.014, indicating this model 
is a good fit of the data. Table 14 shows the coefficient table of ED utilization with age 
indicating how much the ED utilization varies with an independent variable (age) when 
all other independent variables are held constant. The coefficient table shows us that the 
coefficient for age is equal to -.007, indicating that for each one-year increase in age, 
there is a decrease in ED utilization of 0.007 hours, where p<.05.  
Therefore, the statistical analysis for RQ3 accepts the alternate hypothesis that 
there is a correlation between age and ED utilization, where an increased age decreases 
ED utilization. Research question 1 also accepted the hypothesis that there was a 
significant difference in ED utilization in the pre-enrollment to clinic group and post-
enrollment to clinic group, with less ED utilization noted in the post-enrollment to the 
clinic group. Since the patients in the pre-enrollment group were also examined in the 
post-enrollment group, the patients in the post-enrollment group would be naturally older 
due to maturity. Using the findings from the linear regression, where 1.4% of the 
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variability in the ED utilization may have been related to age, which may have impacted 
the significant difference in ED utilization with pre/post-enrollment to clinic findings.  
Table 10 
 
Model Summary for ED Utilization and Age 
 
Model R R Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
1 .120a .014 .012 .460 
a. Predictors: (Constant), AGE 





















-.007 .003 -.120 -2.452 .015 











Research Question 4 
RQ4: Is there a correlation between ED LOS and age among adult sickle cell 
patients in patients between the years of 2012 and 2017? 
To analyze this research question, another linear regression analysis was used. 
The independent variable was age and the dependent variable was ED utilization. Table 
15 shows the Model summary table of ED LOS and age. The R-value is the multiple 
correlation coefficient and has a value of 0.093, indicating a very small level of 
prediction. The R square value is 0.009, indicating that age explains 0.09% of the 
variability of LOS. Table 16 shows the ANOVA table of ED LOS with age. The table 
shows that the independent variable does not statistically significantly predict the 
dependent variable, F(1,410) = 3.592, p>0.05, R square = 0.009, indicating this model is 
not a good fit of the data. Table 17 shows the coefficient table of ED LOS with age 
indicating how much the ED LOS varies with an independent variable (age) when all 
other independent variables are held constant. The coefficient table shows us that the 






Square F Sig. 
1 Regression 1.270 1 1.270 6.012 .015b 
Residual 86.582 410 .211   
Total 87.852 411    
a. Dependent Variable: CODED_EMERGENCY_UTIL 
b. Predictors: (Constant), AGE 
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there is a decrease in ED LOS of 0.053 hours, where p>.05, and therefore no statistical 
significance is noted.  
Therefore, the statistical analysis for RQ4 accepts the null hypothesis that there is 
no correlation between age and ED LOS. Research question 2 also accepted the null 
hypothesis that there was no significant difference in ED LOS in the pre-enrollment to 
clinic group and post-enrollment to clinic group. Using the findings from the linear 
regression and the paired sample t-test, ED LOS was not correlated to age, nor enrollment 
to a sickle cell clinic.  
Table 13 
 
Model Summary for ED LOS and Age 
 
Model R R Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
1 .093a .009 .006 4.245856314
784 
a. Predictors: (Constant), AGE 




ANOVA Test for ED LOS and Age 
 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 64.747 1 64.747 3.592 .059b 
Residual 7391.191 410 18.027   
Total 7455.938 411    
a. Dependent Variable: LOS_ED_ONLY 















Interval for B 





1 (Constant) 5.723 .799  7.166 .000 4.153 7.293 
AGE -.053 .028 -.093 -
1.895 
.059 -.108 .002 
a. Dependent Variable: LOS_ED_ONLY 
 
Conclusion  
 In section 3, I presented the results and findings of this study, including the data 
collection plan, data exclusion, data inclusions, descriptive statistics, and inferential 
statistics. The inferential statistics that were used included cross-tabulations with Chi- 
square test of association and effect size using the Cramer’s V test for research question 
1; and a paired sample t-test to answer research question 2.  
 Research question 1 (RQ1) answered the question: Is there a statistically 
significant difference in ED utilization among adult sickle cell patients before enrollment 
in an adult sickle cell clinic and after enrollment between the years of 2012 and 2017? 
The results from the Chi square analysis found that the null hypothesis was accepted. The 
results of the Cramer’s V association and the Odds ratio noted a statistically significant 
association with ED utilization between pre and post-enrollment to the SCD clinic, 
indicating that after enrollment to the clinic the patients had less ED utilization. 
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Therefore, the null hypothesis for HO1 was rejected and the alternative hypothesis was 
accepted.  
 Research question 2 (RQ2) answered the question: Is there a statistically 
significant difference in ED length of stay among adult sickle cell patients before 
enrollment in an adult sickle cell clinic and after enrollment between the years of 2012 
and 2017? The results of the paired sample t-test found that there was no significant 
difference in ED LOS in the pre-enrollment to the sickle cell clinic group and the post-
enrollment to the sickle cell clinic group. Therefore, the RQ2 results accepted the null 
hypothesis. Although no statistical significance was noted in both groups, the means table 
from the paired sample t-test did show a higher mean LOS in the before clinic enrollment 
group compared to the after-clinic enrollment group.  
 Research question 3 (RQ3) answered the question: Is there a correlation in ED 
utilization and age among adult sickle cell patients? The results of the linear regression 
analysis found that there was a significant correlation in ED utilization and age in adult 
sickle cell patients. Therefore, the RQ3 rejected the null hypothesis and accepted the 
alternate hypothesis.  
 Research question 4 (RQ4) answered the question: Is there a correlation in ED 
LOS and age among adult sickle cell patients? The results of the linear regression 
analysis found that there was no significant correlation in ED LOS and age in adult sickle 
cell patients. Therefore, the RQ4 accepted the null hypothesis. Section 4 includes the 
interpretation of the results, limitations of the study, recommendations, and implications 
for professional practice.  
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Section 4: Application to Professional Practice and Implications for Social Change  
The purpose of this quantitative study was to examine the correlation in ED 
utilization and ED LOS among adult sickle cell patients who received care at an adult 
comprehensive sickle cell clinic pre- and post-enrollment to the center between the years 
of 2012 and 2017. Findings from the chi-square test showed that there was a statistically 
significant difference in ED utilization among adult sickle cell patients before enrollment 
in an adult sickle cell clinic and after enrollment, with a trend to have decreased ED 
utilization post-enrollment. The findings from the paired sample t test showed that there 
was no statistically significant difference in ED LOS among sickle cell patients before 
enrollment in an adult sickle cell clinic and after enrollment. However, the mean ED LOS 
in the pre-enrollment group was greater than the mean ED LOS in the post-enrollment 
group. The results indicated that when SCD patients were enrolled in a comprehensive 
sickle cell center, their ED use was decreased significantly, which indicated improvement 
in patient care and a decrease in overall cost of care related to unnecessary ED utilization.  
The results of this study demonstrated that there are administrative benefits, such 
as decreased ED utilization and possible decreased EDLOS, for patients attending 
comprehensive sickle cell clinics. Decreased ED utilization can decrease unnecessary 
costs by decreasing duplication of services and improve quality of care (Ho et al., 2017). 
It is in the best interest of hospital administrators to pay careful attention to ED 
optimization to improve performance and quality measures (Feinberg & Stone-Griffith, 
2016). Feinberg and Stone-Griffith (2016) stated that hospitals are under regulatory 
pressure to reduce ED costs, improve efficiency, and increase throughput capacity, which 
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then ties to hospital reimbursement. Section 4 contains the interpretation of the findings, 
the limitations of this study, recommendations, the implications for professional practice 
and social change, and a conclusion.  
Sickle Cell Centers 
Fragmented care is a problem for all patients, but for fragile and complicated 
illnesses like sickle cell disease, fragmented care can result in poor outcomes and 
decreased quality of life due to frequent flair-ups and chronic pain (Blinder et al., 2015; 
Koch et al., 2014; Ter-Minassian et al., 2019). Simpson et al. (2017) and Powell et al. 
(2016) provided information on how a multidisciplinary approach affects ED utilization 
in the sickle cell population. The researchers found that monthly meetings, best practice 
advisories, and ED protocols helped to decrease ED visits, ED LOS, IP admissions, and 
IP LOS. The practice of monthly meetings, individualized pain plans for ED protocols, 
and best practice advisories are consistent with comprehensive sickle cell clinics’ 
practices.  
Adult sickle cell centers use a multidisciplinary approach of care, and Powell et 
al. (2016) and Simpson et al. (2017) reported that this improves overall outcomes and 
strengthens relationships with a medical practice that understands best practices for this 
condition. When there is a lack of sickle cell providers, patients with SCD tend to utilize 
ED services more than clinic services due to untreated pain and other symptoms (Blinder 
et al., 2015). The current study focused on a large, comprehensive sickle cell clinic 
associated with a teaching center to examine the association between ED utilization and 
ED LOS.  
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Interpretation of Results 
RQ 1 Analysis 
RQ1 asked the following: Is there a statistically significant difference in ED 
utilization among adult sickle cell patients before enrollment in an adult sickle cell clinic 
and after enrollment between the years of 2012 and 2017? The results indicated that there 
was a statistically significant difference in ED utilization in the pre-enrollment group and 
post-enrollment group, where the ED utilization was higher in the pre-enrollment group 
compared to the post-enrollment group. A chi-square test was used to analyze the data. A 
categorical value of 0 was used for nonemergency utilization, and 1 was used for 
emergency utilization. The alpha value was noted to be .000, which is less than p value of 
.05. Therefore, Ho1was rejected and Ha1was accepted. To assess the type of correlation 
between the groups, the Cramer’s V test was used. The Cramer’s V value was noted to be 
RR= 0.182, where RR < 1, which indicated a negative association between post-
enrollment and ED utilization; however, the effect size was small or weak. The odd’s 
ratio suggested that the counts in the post-enrollment group were 2.221 times more likely 
to use the nonemergency admit types, and less likely to use the Emergency admit type 
(OR = 2.221, 95% CI: 1.448, 3.406).  
RQ2 Analysis 
 RQ2 asked the following: Is there a statistically significant difference in ED 
length of stay among adult sickle cell patients before enrollment in an adult sickle cell 
clinic and after enrollment between the years of 2012 and 2017? The results indicated 
that there was no statistically significant difference in ED LOS in the pre-enrollment and 
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post-enrollment groups. The test used here was a paired sample t test to assess two scale 
variables: the pre-enrollment to the clinic LOS and the post-enrollment to the clinic LOS 
within the same sample group. The findings of the paired sample t test indicated that the 
mean ED LOS of the pre-enrollment to clinic group, m = 28.01 hours, was higher than 
the mean ED LOS of the post-enrollment to clinic group, m = 19.45 hours. The mean 
difference between the before registration to clinic group and the after registration to 
clinic ED LOS group was m = 8.560, 95% CI (6.904, 24.024). However, p = .269 was p > 
.05; therefore, the null hypothesis was accepted, and the alternate hypothesis was 
rejected. The mean ED LOS in the post-enrollment group was less than the ED LOS in 
the pre-enrollment group. The results indicated that although there was no significant 
difference in ED LOS in the two groups, there was still a tendency to have a lower LOS 
in the post-enrollment clinic group compared to the pre-enrollment group.  
RQ3 Analysis 
RQ3 asked the following: Is there a correlation between ED utilization and age 
among adult sickle cell patients in patients between the years of 2012 and 2017? The 
results indicated that there was a significant correlation between ED utilization and age in 
these adult sickle cell patients. A linear regression analysis was used to analyze these 
data. The linear regression was run to predict ED utilization from age. Age statistically 
significantly predicted ED utilization, F(1,410)= 6.012, p < .05, R square = 0.014, 
indicating age added statistically significantly to the prediction of ED utilization, p <  





RQ4 asked the following: Is there a correlation between ED LOS and age among 
adult sickle cell patients in patients between the years of 2012 and 2017? The results 
indicated that there was no significant correlation between ED LOS and age in these adult 
sickle cell patients. A linear regression analysis was used to analyze these findings. Age 
did not statistically significantly predict ED LOS, F(1,410)= 3.592, p > 0.05, R square = 
0.009, indicating age did not statistically significantly predict ED LOS, p > 0.05.  
Interpretation of Findings to Literature 
 I investigated the correlation in ED utilization and ED LOS with SCD patients 
before they were enrolled in a sickle cell center compared to SCD patients after they were 
enrolled in the sickle cell clinic. The findings indicated that there was a statistically 
significant difference in ED utilization among adult sickle cell patients before enrollment 
in an adult sickle cell clinic and after enrollment between the years of 2012 and 2017 
with ED utilization higher in the pre-enrollment group. The findings also indicated that 
there was no statistical difference in ED LOS among adults before or after enrollment to 
the sickle cell clinic. The literature review demonstrated the correlation between 
comprehensive sickle cell centers and ED utilization/ED LOS was mixed, with some 
studies suggesting increased ED utilization (Carden et al., 2016; Lavelle et al., 2018; 
Smeltzer et al., 2016) and some studies suggesting decreased ED utilization (Powell et 
al., 2016; Simpson et al., 2017).  
Previous studies showed that a multidisciplinary approach to SCD care reduced 
the ED utilization and ED LOS (Powell et al., 2016; Simpson et al., 2017). Simpson et al. 
60 
 
(2017) found that using a targeted approach of patient-specific best practice advisories, 
an ED management protocol, and the formation of a medical home for high-utilizer sickle 
cell patients decreased ED utilization, decreased ED LOS, and decreased inpatient 
utilization. Simpson et al. (2017) used a pre-post design but only looked at confidence 
intervals, not statistical significance.  
Additionally, Blinder et al. (2015) found that ED reliance increased in the 
transition-age group due to decreased access to primary care providers and decreased 
engagement with SCD patients. The findings of the current study aligned with previous 
multidisciplinary approaches and that utilizing best practice guidelines can help with 
reducing unnecessary ED utilization. However, no significant differences were noted in 
ED LOS. However, it is worthy to note that the mean LOS in the after enrollment to the 
sickle cell clinic was lower than the mean LOS in the before enrollment to the sickle cell 
clinic group.  
Blinder et al. (2014) found that age and disease severity increased ED utilization. 
Blinder et al. found that between the age of 15 years and 22 years, ED reliance increased 
from 0.17 to 0.29 visits per quarter and remained high throughout adulthood. These 
findings are consistent with findings from the current study, which indicated that age 
increased ED utilization.  
Interpretation of Findings to Theory 
The conceptual framework for this study was the Donabedian framework. The 
Donabedian framework includes three categories: structure, process, and outcome 
(Donabedian, 1985). The structure consists of how care is organized, the process consists 
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of what is known to be the best evidence-based medicine, and the outcome is the quality 
measure that affects the result of care (Donabedian, 1985; Van Houdt et al., 2013). In the 
current study, the structure was the comprehensive sickle cell clinic; the process was the 
best practice standards already researched in sickle cell, which included multidisciplinary 
care and individualized care plans; and the outcome was the use of ED utilization and 
LOS in the ED. The findings from this study indicated that organized care at a 
comprehensive sickle cell clinic can improve patient outcomes such as ED utilization (see 
Figure 4). Although the ED LOS did not show a significant difference between the pre-
enrollment group and post-enrollment group, there was a trend of shorter ED LOS in the 
post-enrollment group. Future studies with a larger sample for the paired sample t test 
should be considered.  
Summary of Key Findings and Interpretations 
The results of this study indicated that there was a statistically significant 
difference in ED utilization in the same group of adult sickle cell patients prior to 
enrollment in an adult sickle cell center and post-enrollment to the center, but no 
significant difference in the ED LOS in a paired sample of adult sickle cell patients was 
noted. The findings suggested that the ED utilization was significantly less in the SCD 
patients who were enrolled to the sickle cell clinic. Additionally, the findings also 
showed no significant differences in ED LOS in SCD patients before or after being 
enrolled in the sickle cell clinic. The results suggest the administrative benefits for 
patients who attend comprehensive sickle cell centers. Unnecessary ED utilization in the 
United States can be managed in physician offices and clinics at a savings of $4.4 billion 
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annually (Enard & Ganelin, 2014). Enard and Ganelin (2014) also reported that 
unnecessary ED utilization can lead to decreased efficiency of the hospital and the 
possibility for more uncompensated care. The current study provided additional evidence 
to support the development of more adult sickle cell clinics. 
Limitations of the Study 
The first limitation was a secondary data set was used to address the research 
questions. Using a secondary data set limits the generalizability of the results. Although 
this data set included a large sample size of 622 patient encounters, this data set included 
data from only one sickle cell clinic. The sickle cell clinic was in one state, which limited 
generalizability to all SCD patients and specialty clinics. Additionally, the data set 
included ED utilization and ED LOS data in only one major health care system rather 
than all of the health care systems in the area. Therefore, if a patient utilized another 
hospital system’s health care ED, these data were not included. I assumed that the SCD 
patient would go to the health care system that the patient considered their medical home. 
Also, the data set included data from the time period of 2012 until 2017 rather than more 
recent data.  
Recommendations 
The limitations of the study indicated opportunities for future research. Future 
studies with data in a more current time frame and observing data for a longer period of 
time would be beneficial to understand changes that occur over time. It would also be 
advantageous to expand the study to multiple states/regions and to utilize data from 
multiple sickle cell centers. Researching more diverse populations may allow the results 
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to be more generalizable. Examining the cost-of-care data with each ED encounter could 
also reveal the potential savings that a sickle cell center could bring to a health care 
system.  
Implications for Professional Practice and Social Change 
The results of this study were intended to provide information for professional 
practice and social change relevant to the administrative benefits of sickle cell centers. 
The results of this study showed the administrative benefits of adult sickle cell patients 
attending a comprehensive sickle cell center, including significant decreased ED 
utilization and possible decreased ED LOS. The study could encourage primary care 
providers, pediatric sickle cell centers, and hematologists to transfer the care of adult 
sickle cell patients to adult sickle cell centers. The results could also encourage the adult 
sickle cell centers to use a multidisciplinary approach, best practice advisories, ED 
protocols, and a framework for treating adult patients with SCD. Additionally, this study 
could help administrators understand the potential savings on health care costs from these 
reduced ED visits, improved efficiency, and reduced ED LOS. The findings of this study 
may contribute to positive social change by policymakers and administrators 
understanding the benefits of SCD centers and investing in more SCD centers in health 
care systems.  
Conclusion 
The study addressed the gap in the literature regarding the administrative benefits 
of adult sickle cell centers. My findings indicated that there was a significant reduction in 
ED utilization among adult sickle cell patients after enrollment in an adult sickle cell 
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center. Based on the findings of this study, hospital administrators and other providers 
may recognize the value of sickle cell centers. Hospital administrators may embrace the 
findings in support of sickle cell centers not only for improved patient outcomes but also 
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